Publications by authors named "R Mohsen"
Aim: Compare the efficiency of selenium nanoparticles (SeNPs) and Nano vitamin D3 in modulating alveolar bone osteoporosis induced by anastrozole in albino rats.
Materials And Methods: 28 female albino rats were randomly divided into 4 groups (7/group); Control group (GP I): rats were received distilled water orally. Anastrozole group (GP II): rats were orally given anastrozole (1 mg/kg/day) dissolved in distilled water.
Article Synopsis
- The study aimed to evaluate the effectiveness of misoprostol before hysteroscopy in women who have never given birth (nulliparous).
- A total of 13 studies involving 1,528 participants were analyzed, comparing misoprostol to various alternatives including placebo and other medications.
- Results indicated mixed outcomes on cervical dilation and pain levels, with a significant reduction in time for cervical dilatation (p=0.03), but no strong evidence for improved ease of dilation or reduced preoperative pain.
Background: There has been significant improvement in treating metastatic non-small-cell lung cancer (mNSCLC) over the past 2 decades. The aim of this study is to describe the use of tyrosine kinase inhibitors (TKIs) in Qatar. This study focuses on the objective response rate (ORR) and reported adverse drug events (ADEs) of TKIs used for the management of patients with mNSCLC.
View Article and Find Full Text PDFTo study the laser acupuncture (LA) effects on postmenopausal obese women's metabolic syndrome. Randomized controlled trial. Benha university hospital.
View Article and Find Full Text PDFArticle Synopsis
- Aplastic anemia is a rare condition where the bone marrow fails to produce enough blood cells, leading to low counts of red and white blood cells and platelets.
- A case report presents a 63-year-old man with advanced lung cancer who developed aplastic anemia after receiving Osimertinib, an EGFR tyrosine kinase inhibitor used for cancer treatment.
- The report highlights the need for awareness of this potential side effect, emphasizes the importance of monitoring patients on Osimertinib, and calls for more research to understand how to manage and mitigate this risk.